209 related articles for article (PubMed ID: 15939745)
1. Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.
Pittman PR; Leitman SF; Oro JG; Norris SL; Marano NM; Ranadive MV; Sink BS; McKee KT
Clin Diagn Lab Immunol; 2005 Jun; 12(6):713-21. PubMed ID: 15939745
[TBL] [Abstract][Full Text] [Related]
2. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
[TBL] [Abstract][Full Text] [Related]
3. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
[TBL] [Abstract][Full Text] [Related]
4. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.
Pittman PR; Cavicchia MA; Kingsbury JL; Johnson NA; Barrera-Oro JG; Schmader T; Korman L; Quinn X; Ranadive M
Vaccine; 2014 Sep; 32(39):5131-9. PubMed ID: 24837771
[TBL] [Abstract][Full Text] [Related]
5. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity.
Pittman PR; Fisher D; Quinn X; Schmader T; Barrera-Oro JG
Vaccine; 2013 Oct; 31(44):5009-14. PubMed ID: 24026013
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
Taft SC; Weiss AA
Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
[TBL] [Abstract][Full Text] [Related]
7. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.
Pittman PR; Norris SL; Barrera Oro JG; Bedwell D; Cannon TL; McKee KT
Vaccine; 2006 Apr; 24(17):3654-60. PubMed ID: 16497418
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.
Bellanti JA; Lin FY; Chu C; Shiloach J; Leppla SH; Benavides GA; Karpas A; Moayeri M; Guo C; Robbins JB; Schneerson R
Clin Vaccine Immunol; 2012 Feb; 19(2):140-5. PubMed ID: 22190398
[TBL] [Abstract][Full Text] [Related]
9. Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats.
Ndumnego OC; Crafford J; Beyer W; van Heerden H
BMC Vet Res; 2013 Dec; 9():265. PubMed ID: 24373579
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.
Clement KH; Rudge TL; Mayfield HJ; Carlton LA; Hester A; Niemuth NA; Sabourin CL; Brys AM; Quinn CP
Clin Vaccine Immunol; 2010 Nov; 17(11):1753-62. PubMed ID: 20739500
[TBL] [Abstract][Full Text] [Related]
11. Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.
Semenova VA; Schmidt DS; Taylor TH; Li H; Steward-Clark E; Soroka SD; Ballard MM; Quinn CP
Vaccine; 2007 Feb; 25(10):1780-8. PubMed ID: 17229495
[TBL] [Abstract][Full Text] [Related]
12. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
Dumas EK; Nguyen ML; Cox PM; Rodgers H; Peterson JL; James JA; Farris AD
Vaccine; 2013 Apr; 31(14):1856-63. PubMed ID: 23415781
[TBL] [Abstract][Full Text] [Related]
13. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.
Crowe SR; Garman L; Engler RJ; Farris AD; Ballard JD; Harley JB; James JA
Vaccine; 2011 May; 29(20):3670-8. PubMed ID: 21420416
[TBL] [Abstract][Full Text] [Related]
14. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
Dumas EK; Garman L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Choudhari S; Picking WD; James JA; Farris AD
Vaccine; 2017 Jun; 35(26):3416-3422. PubMed ID: 28504191
[TBL] [Abstract][Full Text] [Related]
15. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
16. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
[TBL] [Abstract][Full Text] [Related]
17. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
[TBL] [Abstract][Full Text] [Related]
19. Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel.
Singer DE; Schneerson R; Bautista CT; Rubertone MV; Robbins JB; Taylor DN
Vaccine; 2008 Feb; 26(7):869-73. PubMed ID: 18206278
[TBL] [Abstract][Full Text] [Related]
20. In vitro correlate of immunity in a rabbit model of inhalational anthrax.
Pitt ML; Little SF; Ivins BE; Fellows P; Barth J; Hewetson J; Gibbs P; Dertzbaugh M; Friedlander AM
Vaccine; 2001 Sep; 19(32):4768-73. PubMed ID: 11535328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]